POST Online Media Lite Edition


Nile Therapeutics appoints Frank Litvack to board of directors

Staff writer |
San Francisco, Ca., USA - September 25, 2009, San Francisco, Ca., USA - Nile Therapeutics announced the appointment of Frank Litvack to its board of directors.

Article continues below

Dr. Litvack is a seasoned veteran of the cardiovascular healthcare space, with over 25 years of academic and industry experience. Dr. Litvack is a Professor at the David Geffen School of Medicine, University of California, Los Angeles. He is also an accomplished entrepreneur, having orchestrated the founding, development or sale of several medical technology companies including Progressive Angioplasty Systems, Savacor, and most recently the $1.4 billion acquisition of Conor Medsystems by Johnson & Johnson.


What to read next

Nile Therapeutics promotes Darlene Horton to CEO and director
Nile Therapeutics Appoints Gregory W. Schafer to Board of Directors
Home Depot elects Mark Vadon to the board